O	0	2	In
O	3	4	a
O	5	15	randomized
O	16	26	controlled
O	27	32	trial
O	32	33	,
O	34	42	patients
O	43	52	preferred
B-intervention	53	63	electronic
I-intervention	64	68	data
I-intervention	69	79	collection
O	80	82	of
O	83	89	breast
O	90	96	cancer
O	97	101	risk
O	101	102	-
O	102	108	factor
O	109	120	information
O	121	123	in
O	124	125	a
O	126	137	mammography
O	138	145	setting
O	145	146	.

O	147	149	We
O	150	159	evaluated
O	160	167	patient
O	168	178	acceptance
O	179	181	of
O	182	184	an
O	185	195	electronic
O	196	209	questionnaire
O	210	212	to
O	213	220	collect
O	221	227	breast
O	228	234	cancer
O	235	239	risk
O	239	240	-
O	240	246	factor
O	247	251	data
O	252	254	in
O	255	256	a
O	257	268	mammography
O	269	276	setting
O	276	277	.

O	278	280	We
O	281	290	developed
O	291	293	an
O	294	304	electronic
O	305	318	questionnaire
O	319	321	on
O	322	323	a
O	324	330	tablet
O	331	339	computer
O	340	353	incorporating
O	354	363	prefilled
O	364	371	answers
O	372	375	and
O	376	380	skip
O	381	389	patterns
O	389	390	.

O	391	396	Using
O	397	398	a
O	399	409	randomized
O	410	420	controlled
O	421	426	study
O	427	433	design
O	433	434	,
O	435	437	we
O	438	444	tested
O	445	448	the
O	449	455	survey
O	456	458	in
O	459	460	a
O	461	472	mammography
O	473	479	clinic
O	480	484	that
O	485	496	administers
O	497	498	a
O	499	504	paper
O	505	509	risk
O	509	510	-
O	510	516	factor
O	517	530	questionnaire
O	531	533	to
O	534	539	every
O	540	545	woman
O	546	548	at
O	549	552	her
O	553	562	screening
O	563	572	mammogram
O	572	573	.

O	574	576	We
O	577	587	randomized
B-total-participants	588	591	160
O	592	597	women
O	598	600	to
O	601	604	use
O	605	608	the
O	609	619	electronic
O	620	626	survey
O	627	628	(
O	628	640	experimental
O	641	646	group
O	646	647	,
O	648	649	n
O	650	651	=
B-intervention-participants	652	654	86
O	654	655	)
O	656	658	or
B-control	659	664	paper
I-control	665	671	survey
O	672	673	(
O	673	680	control
O	681	686	group
O	686	687	,
O	688	689	n
O	690	691	=
B-control-participants	692	694	74
O	694	695	)
O	695	696	.

O	697	699	We
O	700	709	evaluated
O	710	717	patient
O	718	728	acceptance
O	729	732	and
O	733	737	data
O	738	750	completeness
O	750	751	.

O	752	759	Overall
O	759	760	,
B-iv-bin-percent	761	763	70
I-iv-bin-percent	763	764	.
I-iv-bin-percent	764	765	4
I-iv-bin-percent	765	766	%
O	767	769	of
O	770	773	the
O	774	786	experimental
O	787	792	group
O	793	798	women
O	799	806	thought
O	807	810	the
B-outcome	811	817	survey
I-outcome	818	821	was
I-outcome	822	826	very
I-outcome	827	831	easy
I-outcome	832	834	to
I-outcome	835	838	use
O	838	839	,
O	840	848	compared
O	849	851	to
B-cv-bin-percent	852	854	55
I-cv-bin-percent	854	855	.
I-cv-bin-percent	855	856	6
I-cv-bin-percent	856	857	%
O	858	860	of
O	861	866	women
O	867	869	in
O	870	873	the
O	874	881	control
O	882	887	group
O	887	888	.

B-iv-bin-percent	889	895	Ninety
I-iv-bin-percent	896	903	percent
O	904	906	of
O	907	919	experimental
O	920	925	group
O	926	931	women
B-outcome	932	941	preferred
I-outcome	942	947	using
I-outcome	948	951	the
I-outcome	952	958	tablet
O	958	959	,
O	960	968	compared
O	969	971	to
O	972	975	the
O	976	981	paper
O	982	995	questionnaire
O	995	996	.

O	997	1007	Preference
O	1008	1011	for
O	1012	1015	the
O	1016	1022	tablet
O	1023	1026	did
O	1027	1030	not
O	1031	1037	differ
O	1038	1040	by
O	1041	1044	age
O	1044	1045	;
O	1046	1053	however
O	1053	1054	,
O	1055	1060	women
O	1061	1062	>
O	1063	1065	or
O	1066	1067	=
O	1068	1070	60
O	1071	1076	years
O	1077	1080	did
O	1081	1084	not
O	1085	1089	find
O	1090	1093	the
O	1094	1100	tablet
O	1101	1103	as
O	1104	1108	easy
O	1109	1111	to
O	1112	1115	use
O	1116	1118	as
O	1119	1122	did
O	1123	1128	women
O	1129	1130	<
O	1131	1133	60
O	1134	1139	years
O	1139	1140	.

O	1141	1144	The
B-outcome	1145	1155	proportion
I-outcome	1156	1158	of
I-outcome	1159	1166	missing
I-outcome	1167	1171	data
O	1172	1175	was
O	1176	1189	significantly
O	1190	1195	lower
O	1196	1198	on
O	1199	1202	the
O	1203	1209	tablet
O	1210	1218	compared
O	1219	1221	to
O	1222	1225	the
O	1226	1231	paper
O	1232	1245	questionnaire
O	1246	1247	(
B-iv-bin-percent	1247	1248	4
I-iv-bin-percent	1248	1249	.
I-iv-bin-percent	1249	1250	6
I-iv-bin-percent	1250	1251	%
O	1252	1254	vs
O	1254	1255	.
B-cv-bin-percent	1256	1257	6
I-cv-bin-percent	1257	1258	.
I-cv-bin-percent	1258	1259	2
I-cv-bin-percent	1259	1260	%
O	1260	1261	,
O	1262	1263	P
O	1264	1265	=
O	1266	1267	.
O	1267	1269	04
O	1269	1270	)
O	1270	1271	.

O	1272	1282	Electronic
O	1283	1297	questionnaires
O	1298	1301	are
O	1302	1310	feasible
O	1311	1313	to
O	1314	1317	use
O	1318	1320	in
O	1321	1322	a
O	1323	1334	mammography
O	1335	1342	setting
O	1342	1343	,
O	1344	1347	can
O	1348	1355	improve
O	1356	1360	data
O	1361	1368	quality
O	1368	1369	,
O	1370	1373	and
O	1374	1377	are
O	1378	1387	preferred
O	1388	1390	by
O	1391	1396	women
O	1397	1407	regardless
O	1408	1410	of
O	1411	1414	age
O	1414	1415	.
